Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Fludeoxyglucose (18F) Radionuclide Injection Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Cancer
      • 1.3.3 Coronary Artery Disease
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Diagnostics Center
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Production Value 2014-2025
      • 2.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Production 2014-2025
      • 2.1.3 Global Fludeoxyglucose (18F) Radionuclide Injection Capacity 2014-2025
      • 2.1.4 Global Fludeoxyglucose (18F) Radionuclide Injection Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size CAGR of Key Regions
      • 2.2.2 Global Fludeoxyglucose (18F) Radionuclide Injection Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Capacity by Manufacturers
      • 3.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Fludeoxyglucose (18F) Radionuclide Injection Revenue by Manufacturers (2014-2019)
      • 3.2.2 Fludeoxyglucose (18F) Radionuclide Injection Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Fludeoxyglucose (18F) Radionuclide Injection Market Concentration Ratio (CR5 and HHI)
    • 3.3 Fludeoxyglucose (18F) Radionuclide Injection Price by Manufacturers
    • 3.4 Key Manufacturers Fludeoxyglucose (18F) Radionuclide Injection Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Fludeoxyglucose (18F) Radionuclide Injection Market
    • 3.6 Key Manufacturers Fludeoxyglucose (18F) Radionuclide Injection Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Cancer Production and Production Value (2014-2019)
      • 4.1.2 Coronary Artery Disease Production and Production Value (2014-2019)
      • 4.1.3 Others Production and Production Value (2014-2019)
    • 4.2 Global Fludeoxyglucose (18F) Radionuclide Injection Production Market Share by Type
    • 4.3 Global Fludeoxyglucose (18F) Radionuclide Injection Production Value Market Share by Type
    • 4.4 Fludeoxyglucose (18F) Radionuclide Injection Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application

    6 Production by Regions

    • 6.1 Global Fludeoxyglucose (18F) Radionuclide Injection Production (History Data) by Regions 2014-2019
    • 6.2 Global Fludeoxyglucose (18F) Radionuclide Injection Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Fludeoxyglucose (18F) Radionuclide Injection Production Growth Rate 2014-2019
      • 6.3.2 United States Fludeoxyglucose (18F) Radionuclide Injection Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Fludeoxyglucose (18F) Radionuclide Injection Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Fludeoxyglucose (18F) Radionuclide Injection Production Growth Rate 2014-2019
      • 6.4.2 European Union Fludeoxyglucose (18F) Radionuclide Injection Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Fludeoxyglucose (18F) Radionuclide Injection Import & Export
    • 6.5 China
      • 6.5.1 China Fludeoxyglucose (18F) Radionuclide Injection Production Growth Rate 2014-2019
      • 6.5.2 China Fludeoxyglucose (18F) Radionuclide Injection Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Fludeoxyglucose (18F) Radionuclide Injection Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Fludeoxyglucose (18F) Radionuclide Injection Consumption by Regions

    • 7.1 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Fludeoxyglucose (18F) Radionuclide Injection Consumption by Type
      • 7.2.2 United States Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Fludeoxyglucose (18F) Radionuclide Injection Consumption by Type
      • 7.3.2 European Union Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application
    • 7.4 China
      • 7.4.1 China Fludeoxyglucose (18F) Radionuclide Injection Consumption by Type
      • 7.4.2 China Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Fludeoxyglucose (18F) Radionuclide Injection Consumption by Type
      • 7.5.2 Rest of World Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Zevacor Pharma
      • 8.1.1 Zevacor Pharma Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Fludeoxyglucose (18F) Radionuclide Injection
      • 8.1.4 Fludeoxyglucose (18F) Radionuclide Injection Product Introduction
      • 8.1.5 Zevacor Pharma Recent Development
    • 8.2 Queen's PET Imaging
      • 8.2.1 Queen's PET Imaging Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Fludeoxyglucose (18F) Radionuclide Injection
      • 8.2.4 Fludeoxyglucose (18F) Radionuclide Injection Product Introduction
      • 8.2.5 Queen's PET Imaging Recent Development
    • 8.3 Triad Isotopes
      • 8.3.1 Triad Isotopes Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Fludeoxyglucose (18F) Radionuclide Injection
      • 8.3.4 Fludeoxyglucose (18F) Radionuclide Injection Product Introduction
      • 8.3.5 Triad Isotopes Recent Development
    • 8.4 NCM USA Bronx
      • 8.4.1 NCM USA Bronx Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Fludeoxyglucose (18F) Radionuclide Injection
      • 8.4.4 Fludeoxyglucose (18F) Radionuclide Injection Product Introduction
      • 8.4.5 NCM USA Bronx Recent Development
    • 8.5 Spectron MRC
      • 8.5.1 Spectron MRC Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Fludeoxyglucose (18F) Radionuclide Injection
      • 8.5.4 Fludeoxyglucose (18F) Radionuclide Injection Product Introduction
      • 8.5.5 Spectron MRC Recent Development
    • 8.6 Petnet Solutions
      • 8.6.1 Petnet Solutions Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Fludeoxyglucose (18F) Radionuclide Injection
      • 8.6.4 Fludeoxyglucose (18F) Radionuclide Injection Product Introduction
      • 8.6.5 Petnet Solutions Recent Development
    • 8.7 Shertech Laboratories
      • 8.7.1 Shertech Laboratories Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Fludeoxyglucose (18F) Radionuclide Injection
      • 8.7.4 Fludeoxyglucose (18F) Radionuclide Injection Product Introduction
      • 8.7.5 Shertech Laboratories Recent Development
    • 8.8 Precision Nuclear
      • 8.8.1 Precision Nuclear Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Fludeoxyglucose (18F) Radionuclide Injection
      • 8.8.4 Fludeoxyglucose (18F) Radionuclide Injection Product Introduction
      • 8.8.5 Precision Nuclear Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Fludeoxyglucose (18F) Radionuclide Injection Production Forecast by Type
      • 9.7.2 Global Fludeoxyglucose (18F) Radionuclide Injection Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Fludeoxyglucose (18F) Radionuclide Injection Sales Channels
      • 10.2.2 Fludeoxyglucose (18F) Radionuclide Injection Distributors
    • 10.3 Fludeoxyglucose (18F) Radionuclide Injection Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).
      Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market.
      United States is expected to dominate the global Fludeoxyglucose (18F) Radionuclide Injection market due to high healthcare infrastructure.
      ter United States, Fludeoxyglucose (18F) Radionuclide Injection market is then followed by Europe and Asia-Pacific. Europe market is expected to grow due to rise in the number of manufacturing companies of Fludeoxyglucose (18F) Radionuclide Injection. In Asia-Pacific, India and China are expected to be major market owing to increasing geriatric population and cancer incidences.
      In 2019, the market size of Fludeoxyglucose (18F) Radionuclide Injection is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Fludeoxyglucose (18F) Radionuclide Injection.

      This report studies the global market size of Fludeoxyglucose (18F) Radionuclide Injection, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Fludeoxyglucose (18F) Radionuclide Injection production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Zevacor Pharma
      Queen's PET Imaging
      Triad Isotopes
      NCM USA Bronx
      Spectron MRC
      Petnet Solutions
      Shertech Laboratories
      Precision Nuclear

      Market Segment by Product Type
      Cancer
      Coronary Artery Disease
      Others

      Market Segment by Application
      Hospitals
      Clinics
      Diagnostics Center

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Fludeoxyglucose (18F) Radionuclide Injection status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Fludeoxyglucose (18F) Radionuclide Injection manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Fludeoxyglucose (18F) Radionuclide Injection are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now